NewslettersCell Therapy News Targeting Orthotopic and Metastatic Pancreatic Cancer with Allogeneic Stem Cell-Engineered Mesothelin-Redirected CAR-NKT Cells By Jamie Kang - December 1, 2025 0 126 Researchers developed an off-the-shelf immunotherapy using gene-engineered natural killer T cells derived from stem cells called Allo15MCAR-NKT cells. [Proceedings of The National Academy of Sciences of The United States of America] Full Article